Is there evidence for symptoms of cannabis withdrawal in the national epidemiologic survey of alcohol and related conditions?
paper
Cited
Public
Unavailable
- Authors
- Agrawal, Arpana; Pergadia, Michele L; Lynskey, Michael T
- Year
- 2008
- Journal
- The American journal on addictions
- PMID
- 18463997
- DOI
- 10.1080/10550490802019519
We examined the prevalence of 20 individual symptoms of cannabis withdrawal in the U.S. general population. More than 29% of past 12-month cannabis users reported experiencing at least two cannabis withdrawal symptoms, with 8% reporting impairment from at least two symptoms or withdrawal relief. The most common withdrawal symptom was eating more than usual/gaining weight. Co-occurring tobacco use modestly increased the likelihood of reporting certain symptoms, as did other illicit drug use, though to a lesser degree. Even after controlling for intensity of cannabis use, a history of parental alcohol/drug problems was associated with an increased likelihood of experiencing cannabis withdrawal. Evidence from this and prior studies demonstrating withdrawal strongly suggest that future editions of DSM need to reconsider the exclusion of withdrawal from criteria for cannabis dependence.
No figures extracted from this document.
No chunks — full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
Not in any collection.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Investigating mood-modification, withdrawal, and sensitization in compulsive sexual behaviour. | Sassover E et al. | — | 2024 | → |
| Classifying risky cannabis involvement in young adults using the Marijuana Consequences Questionnaire (MACQ). | Read JP et al. | — | 2022 | → |
| Evidence for spontaneous cannabinoid withdrawal in mice. | Paronis C et al. | — | 2022 | → |
| Progression of cannabis withdrawal symptoms in people using medical cannabis for chronic pain. | Coughlin LN et al. | — | 2021 | → |
| The role of withdrawal in mesocorticolimbic drug cue reactivity in opioid use disorder. | Shi Z et al. | — | 2021 | → |
| Prevalence of Cannabis Withdrawal Symptoms Among People With Regular or Dependent Use of Cannabinoids: A Systematic Review and Meta-analysis. | Bahji A et al. | — | 2020 | → |
| Cannabis and mental illness: a review. | Lowe DJE et al. | — | 2019 | → |
| Correlates and Potential Confounds of Cannabis Withdrawal Among High-Risk Adolescents. | Ellingson JM et al. | — | 2019 | → |
| Dependence, withdrawal and rebound of CNS drugs: an update and regulatory considerations for new drugs development. | Lerner A et al. | — | 2019 | → |
| DSM-5 cannabis withdrawal syndrome: Demographic and clinical correlates in U.S. adults. | Livne O et al. | — | 2019 | → |
| Pharmacotherapies for cannabis dependence. | Nielsen S et al. | — | 2019 | → |
| Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective. | Cooper ZD et al. | — | 2018 | → |
| The interaction of gender and cannabis in early phase psychosis. | Crocker CE et al. | — | 2018 | → |
| US Epidemiology of Cannabis Use and Associated Problems. | Hasin DS | — | 2018 | → |
| The cannabis withdrawal syndrome: current insights. | Bonnet U et al. | — | 2017 | → |
| Cannabis withdrawal and sleep: A systematic review of human studies. | Gates P et al. | — | 2016 | → |
| Cannabis Withdrawal, Posttreatment Abstinence, and Days to First Cannabis Use Among Emerging Adults in Substance Use Treatment: A Prospective Study. | Davis JP et al. | — | 2016 | → |
| Sex Differences in Cannabis Use and Effects: A Cross-Sectional Survey of Cannabis Users. | Cuttler C et al. | — | 2016 | → |
| Nosologic Comparisons of DSM-IV and DSM-5 Alcohol and Drug Use Disorders: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III. | Goldstein RB et al. | — | 2015 | → |
| Sex differences in cannabis withdrawal symptoms among treatment-seeking cannabis users. | Herrmann ES et al. | — | 2015 | → |
| The National Epidemiologic Survey on Alcohol and Related Conditions (NESARC) Waves 1 and 2: review and summary of findings. | Hasin DS et al. | — | 2015 | → |
| Abstinence phenomena of chronic cannabis-addicts prospectively monitored during controlled inpatient detoxification: cannabis withdrawal syndrome and its correlation with delta-9-tetrahydrocannabinol and -metabolites in serum. | Bonnet U et al. | — | 2014 | → |
| Cannabis withdrawal syndrome: An important diagnostic consideration in adolescents presenting with disordered eating. | Chesney T et al. | — | 2014 | → |
| DSM-5 cannabis use disorder: a phenotypic and genomic perspective. | Agrawal A et al. | — | 2014 | → |
| Pharmacotherapies for cannabis dependence. | Marshall K et al. | — | 2014 | → |
| The prevalence of cannabis withdrawal and its influence on adolescents' treatment response and outcomes: a 12-month prospective investigation. | Greene MC et al. | — | 2014 | → |
| A genetic perspective on the proposed inclusion of cannabis withdrawal in DSM-5. | Verweij KJ et al. | — | 2013 | → |
| DSM-5 criteria for substance use disorders: recommendations and rationale. | Hasin DS et al. | — | 2013 | → |
| Clinical correlates of co-occurring cannabis and tobacco use: a systematic review. | Peters EN et al. | — | 2012 | → |
| Compulsive use of dopamine replacement therapy among Parkinson's disease patients: if it looks like a duck, swims like a duck and quacks like a duck... | Kaye S | — | 2012 | → |
| Diagnostic criteria for cannabis withdrawal syndrome. | Gorelick DA et al. | — | 2012 | → |
| Drug withdrawal-induced depression: serotonergic and plasticity changes in animal models. | Renoir T et al. | — | 2012 | → |
| Quantifying the clinical significance of cannabis withdrawal. | Allsop DJ et al. | — | 2012 | → |
| The co-occurring use and misuse of cannabis and tobacco: a review. | Agrawal A et al. | — | 2012 | → |
| The Cannabis Withdrawal Scale development: patterns and predictors of cannabis withdrawal and distress. | Allsop DJ et al. | — | 2011 | → |
| Cannabis withdrawal severity and short-term course among cannabis-dependent adolescent and young adult inpatients. | Preuss UW et al. | — | 2010 | → |
| Cannabis withdrawal symptoms in non-treatment-seeking adult cannabis smokers. | Levin KH et al. | — | 2010 | → |
| Linkage analyses of cannabis dependence, craving, and withdrawal in the San Francisco family study. | Ehlers CL et al. | — | 2010 | → |
| Self-reported sleep disturbances during cannabis withdrawal in cannabis-dependent outpatients with and without opioid dependence. | Vorspan F et al. | — | 2010 | → |
| Sociodemographic characteristics of cannabis smokers and the experience of cannabis withdrawal. | Copersino ML et al. | — | 2010 | → |
| Central side-effects of therapies based on CB1 cannabinoid receptor agonists and antagonists: focus on anxiety and depression. | Moreira FA et al. | — | 2009 | → |